Primary Gene Identifiers
| Database | Identifier | Description |
|---|
| HGNC | HGNC:10593 | Approved symbol: SCN5A |
| Ensembl | ENSG00000183873 | Human gene |
| NCBI Entrez | 6331 | Gene ID |
| OMIM | 600163 | Gene/locus entry |
Gene Names and Aliases
- Approved Name: Sodium voltage-gated channel alpha subunit 5
- Locus Group: Protein-coding gene
- Gene Family: Sodium voltage-gated channel alpha subunits
- Aliases: Nav1.5, LQT3, HB1, HB2, HBBD, PFHB1, IVF, HH1, SSS1, CDCD2, CMPD2, ICCD
- Previous Symbols: CMD1E
Genomic Location
| Attribute | Value |
|---|
| Chromosome | 3 |
| Cytogenetic Band | 3p22.2 |
| Start Position (GRCh38) | 38,548,057 |
| End Position (GRCh38) | 38,649,743 |
| Strand | Minus (-) |
| Genomic Accession | NC_000003.12 |
| Gene Length | ~101.7 kb |
Section 2: Transcript Identifiers
Ensembl Transcripts
Total Transcripts: 16
| Transcript ID | Biotype | Start | End |
|---|
| ENST00000333535 | protein_coding | 38,548,062 | 38,649,687 |
| ENST00000413689 | protein_coding | 38,548,062 | 38,649,687 |
| ENST00000423572 | protein_coding | 38,548,062 | 38,649,687 |
| ENST00000327956 | protein_coding | 38,548,062 | 38,645,776 |
| ENST00000414099 | protein_coding | 38,548,057 | 38,633,349 |
| ENST00000449557 | protein_coding | 38,550,321 | 38,633,316 |
| ENST00000450102 | protein_coding | 38,549,968 | 38,633,349 |
| ENST00000455624 | protein_coding | 38,549,128 | 38,633,332 |
| ENST00000970295 | protein_coding | 38,548,063 | 38,649,678 |
| ENST00000713730 | nonsense_mediated_decay | 38,548,062 | 38,649,687 |
| ENST00000713731 | nonsense_mediated_decay | 38,587,320 | 38,649,743 |
| ENST00000464652 | protein_coding_CDS_not_defined | 38,552,981 | 38,554,549 |
| ENST00000476683 | retained_intron | 38,629,842 | 38,633,220 |
| ENST00000491944 | retained_intron | 38,614,028 | 38,649,673 |
| ENST00000718272 | retained_intron | 38,632,830 | 38,645,760 |
| ENST00000718273 | retained_intron | 38,632,830 | 38,649,687 |
RefSeq Transcripts (Human)
Total mRNA transcripts: 11
| Accession | Status | MANE Select |
|---|
| NM_000335 | REVIEWED | ✓ YES (Canonical) |
| NM_001099404 | REVIEWED | No |
| NM_001099405 | REVIEWED | No |
| NM_001160160 | REVIEWED | No |
| NM_001160161 | REVIEWED | No |
| NM_001354701 | REVIEWED | No |
| NM_001407185 | REVIEWED | No |
| NM_001407186 | REVIEWED | No |
| NM_001407187 | REVIEWED | No |
| NM_198056 | REVIEWED | No |
| NR_176299 | REVIEWED (ncRNA) | No |
CCDS IDs
Total: 6 consensus coding sequences
| CCDS ID |
|---|
| CCDS46796 |
| CCDS46797 |
| CCDS46798 |
| CCDS46799 |
| CCDS54569 |
| CCDS54570 |
Exon Information (Canonical Transcript ENST00000333535)
Total Exons: 28
| Exon ID | Start | End | Strand |
|---|
| ENSE00004021056 | 38,649,531 | 38,649,687 | - |
| ENSE00001779170 | 38,633,035 | 38,633,359 | - |
| ENSE00003585523 | 38,630,311 | 38,630,429 | - |
| ENSE00003562400 | 38,622,400 | 38,622,489 | - |
| ENSE00003464330 | 38,620,843 | 38,620,971 | - |
| ENSE00001414724 | 38,609,734 | 38,609,964 | - |
| ENSE00004014127 | 38,613,743 | 38,613,834 | - |
| ENSE00001330780 | 38,608,151 | 38,608,214 | - |
| ENSE00001299736 | 38,606,669 | 38,606,810 | - |
| ENSE00001320962 | 38,605,951 | 38,606,148 | - |
| ENSE00001300791 | 38,604,729 | 38,604,908 | - |
| ENSE00001322079 | 38,603,712 | 38,604,083 | - |
| ENSE00001300049 | 38,598,918 | 38,599,050 | - |
| ENSE00001329449 | 38,597,729 | 38,597,967 | - |
| ENSE00001306185 | 38,587,400 | 38,587,573 | - |
| ENSE00001315108 | 38,585,691 | 38,586,041 | - |
| ENSE00001302724 | 38,580,931 | 38,581,371 | - |
| ENSE00001321647 | 38,579,334 | 38,579,495 | - |
| ENSE00001308928 | 38,576,661 | 38,576,781 | - |
| ENSE00001328382 | 38,575,297 | 38,575,451 | - |
| ENSE00001304836 | 38,566,409 | 38,566,582 | - |
| ENSE00001293012 | 38,562,415 | 38,562,537 | - |
| ENSE00001301918 | 38,560,147 | 38,560,428 | - |
| ENSE00004014126 | 38,557,231 | 38,557,284 | - |
| ENSE00001425187 | 38,556,441 | 38,556,578 | - |
| ENSE00001647919 | 38,555,656 | 38,555,760 | - |
| ENSE00003534979 | 38,554,279 | 38,554,549 | - |
| ENSE00004014129 | 38,548,062 | 38,551,558 | - |
Section 3: Protein Identifiers
UniProt Accessions
Total: 9 entries
| Accession | Status | Description |
|---|
| Q14524 | ✓ Canonical/Reviewed | Sodium channel protein type 5 subunit alpha |
| A0A0A0MT39 | Unreviewed | Isoform |
| A0AAQ5BGT0 | Unreviewed | Isoform |
| A0AAQ5BGV8 | Unreviewed | Isoform |
| A3EY21 | Unreviewed | Isoform |
| E9PG18 | Unreviewed | Isoform |
| E9PHB6 | Unreviewed | Isoform |
| H9KVD2 | Unreviewed | Isoform |
| K4DIA1 | Unreviewed | Isoform |
Canonical Protein Properties (Q14524)
| Property | Value |
|---|
| Protein Name | Sodium channel protein type 5 subunit alpha |
| Alternative Names | Nav1.5, hH1, Voltage-gated sodium channel subunit alpha Nav1.5 |
| Sequence Length | 2,016 amino acids |
| Molecular Mass | 226,940 Da |
RefSeq Protein Accessions (Human)
| Accession | Status | MANE Select |
|---|
| NP_000326 | REVIEWED | ✓ YES (Canonical) |
| NP_001092874 | REVIEWED | No |
| NP_001092875 | REVIEWED | No |
| NP_001153632 | REVIEWED | No |
| NP_001153633 | REVIEWED | No |
| NP_001341630 | REVIEWED | No |
| NP_001394114 | REVIEWED | No |
| NP_001394115 | REVIEWED | No |
| NP_001394116 | REVIEWED | No |
| NP_932173 | REVIEWED | No |
Protein Domains and Families
InterPro Domains: 9
| InterPro ID | Name | Type |
|---|
| IPR001696 | Na_channel_asu | Family |
| IPR005821 | Ion_trans_dom | Domain |
| IPR008053 | Na_channel_a5su | Family |
| IPR010526 | Na_trans_assoc_dom | Domain |
| IPR024583 | Na_trans_cytopl | Domain |
| IPR027359 | Volt_channel_dom_sf | Homologous_superfamily |
| IPR043203 | VGCC_Ca_Na | Family |
| IPR044564 | Na_chnl_inactivation_gate | Domain |
| IPR058542 | IQ_SCN5A_C | Domain |
Pfam Domains: 4
| Pfam ID | Description |
|---|
| PF00520 | Ion transport protein |
| PF06512 | Sodium ion transport-associated |
| PF11933 | Sodium channel cytoplasmic domain |
| PF24609 | IQ motif (SCN5A C-terminal) |
Section 4: Structure Identifiers
Experimental Structures (PDB)
Total: 14 structures
| PDB ID | Method | Resolution | Description |
|---|
| 2KBI | NMR | - | C-terminal EF-hand domain of NaV1.5 |
| 2L53 | NMR | - | Apo-CaM in complex with IQ motif of NaV1.5 |
| 4DCK | X-ray | 2.2 Å | C-terminus with FGF13 and CaM |
| 4DJC | X-ray | 1.35 Å | NaV1.5 DIII-IV-Ca/CaM complex |
| 4JQ0 | X-ray | 3.84 Å | C-terminal with FGF12B and Ca²⁺/CaM |
| 4OVN | X-ray | 2.8 Å | C-terminal with CaM poised for activation |
| 5DBR | X-ray | 2.25 Å | Ca²⁺ CaM with inactivation gate |
| 6LQA | Cryo-EM | 3.3 Å | Nav1.5 with quinidine |
| 6MUD | X-ray | 2.69 Å | C-terminal with Ca²⁺/CaM |
| 7DTC | Cryo-EM | 3.3 Å | Nav1.5-E1784K mutant |
| 7L83 | NMR | - | DIV S3b-S4a paddle motif in DPC micelle |
| 8VYJ | Cryo-EM | 3.6 Å | Full-length human cardiac sodium channel - Class-I |
| 8VYK | Cryo-EM | 3.9 Å | Full-length human cardiac sodium channel - Class-II |
| 9ITH | Cryo-EM | 3.4 Å | Nav1.5 in complex with TTX |
Predicted Structures (AlphaFold)
| Model ID | Global pLDDT | Sequence Length | Fraction pLDDT Very High |
|---|
| AF-Q14524-F1 | 68.02 | 15,951 residues (full model) | 12% |
Section 5: Cross-Species Orthologs
| Organism | Gene ID | Symbol | Biotype |
|---|
| Mouse (Mus musculus) | ENSMUSG00000032511 | Scn5a | protein_coding |
| Rat (Rattus norvegicus) | ENSRNOG00000015049 | Scn5a | protein_coding |
| Zebrafish (Danio rerio) | No direct ortholog found | - | - |
| Fruit fly (Drosophila) | No direct ortholog found | - | - |
| Worm (C. elegans) | No direct ortholog found | - | - |
| Yeast (S. cerevisiae) | No ortholog | - | - |
| Note | Total paralogs in human genome |
|---|
| SCN5A orthologs are found in mammals; voltage-gated sodium channels have different gene families in invertebrates. | 26 (other sodium channel alpha subunits) | |
| | Clinical Variants & AI Predictions** |
ClinVar Variant Summary
Total Variants: 4,334
| Classification | Count (estimated) |
|---|
| Pathogenic | ~200+ |
| Likely Pathogenic | ~100+ |
| Uncertain Significance (VUS) | ~3,500+ |
| Likely Benign | ~200+ |
| Benign | ~100+ |
| Conflicting | ~50+ |
TOP 50 Pathogenic/Likely Pathogenic Variants
| Variant ID | HGVS Notation | Type | Classification |
|---|
| 201438 | c.664C>T (p.Arg222Ter) | SNV | Pathogenic |
| 201443 | c.1080G>A (p.Trp360Ter) | SNV | Pathogenic |
| 201447 | c.1134T>A (p.Tyr378Ter) | SNV | Pathogenic |
| 1072847 | c.934+1G>A | Splice | Pathogenic |
| 201427 | c.611+1G>A | Splice | Pathogenic |
| 1408176 | c.217C>T (p.Gln73Ter) | SNV | Pathogenic |
| 179338 | c.3992del (p.Pro1331fs) | Deletion | Pathogenic |
| 179829 | c.1936del (p.Gln646fs) | Deletion | Pathogenic |
| 1076513 | c.901del (p.Trp301fs) | Deletion | Pathogenic |
| 1073809 | c.4085del (p.Cys1362fs) | Deletion | Pathogenic |
| 201555 | c.1711del (p.Ser571fs) | Deletion | Pathogenic |
| 201557 | c.1753del (p.His585fs) | Deletion | Pathogenic |
| 201558 | c.2103del (p.Leu702fs) | Deletion | Pathogenic |
| 1214434 | c.2274del (p.Ile759fs) | Deletion | Pathogenic |
| 1185878 | c.3762del (p.Leu1255fs) | Deletion | Pathogenic |
| 1733997 | c.3693del (p.Lys1232fs) | Deletion | Pathogenic |
| 1737836 | c.40del (p.Arg14fs) | Deletion | Pathogenic |
| 201560 | c.2550_2551dup (p.Phe851fs) | Indel | Pathogenic |
| 201561 | c.2582_2583del (p.Phe861fs) | Deletion | Pathogenic |
| 1386100 | c.2533dup (p.Val845fs) | Duplication | Pathogenic |
| 201566 | c.3488dup (p.Glu1164fs) | Duplication | Pathogenic |
| 201567 | c.3514_3515del (p.Val1172fs) | Deletion | Pathogenic |
| 1012143 | c.4265_4294del (p.Asp1422_Arg1431del) | Deletion | Pathogenic |
| 201571 | c.4516_4524del (p.Gln1506_Pro1508del) | Deletion | Pathogenic |
| 1449654 | c.4492AAG[1] (p.Lys1499del) | Microsatellite | Pathogenic |
| 217838 | c.4769G>A (p.Trp1590Ter) | SNV | Pathogenic |
| 216141 | c.4179C>G (p.Tyr1393Ter) | SNV | Pathogenic |
| 242199 | c.4891C>T (p.Arg1631Cys) | SNV | Pathogenic |
| 1788496 | c.2254G>C (p.Gly752Arg) | SNV | Pathogenic |
| 2107170 | c.1947T>A (p.Cys649Ter) | SNV | Pathogenic |
| 1072446 | c.2618C>G (p.Ser873Ter) | SNV | Pathogenic |
| 1076635 | c.3394G>T (p.Glu1132Ter) | SNV | Pathogenic |
| 1075437 | c.4837A>T (p.Lys1613Ter) | SNV | Pathogenic |
| 1187556 | c.2230G>T (p.Glu744Ter) | SNV | Pathogenic |
| 1374462 | c.578G>A (p.Trp193Ter) | SNV | Pathogenic |
| 1375303 | c.4316G>A (p.Trp1439Ter) | SNV | Pathogenic |
| 201580 | c.2023+2T>A | Splice | Pathogenic |
| 1502060 | c.1140+2T>G | Splice | Pathogenic |
| 2026498 | c.3960+1G>T | Splice | Pathogenic |
| 1067586 | c.2024-1G>A | Splice | Likely Pathogenic |
| 1068181 | c.4296+1G>T | Splice | Likely Pathogenic |
| 1066010 | c.3961G>T (p.Val1321Leu) | SNV | Likely Pathogenic |
| 1066904 | Deletion g.38591792_38593069 | Deletion | Likely Pathogenic |
| 1071777 | c.334dup (p.Tyr112fs) | Duplication | Pathogenic |
| 1073629 | c.4320dup (p.Tyr1441fs) | Duplication | Pathogenic |
| 1076515 | c.3758del (p.Met1253fs) | Deletion | Pathogenic |
| 1527869 | c.2678G>T (p.Arg893Leu) | SNV | Pathogenic |
| 2027105 | c.206del (p.Gly69fs) | Deletion | Pathogenic |
| 2027600 | c.5295G>C (p.Met1765Ile) | SNV | Pathogenic |
| 201593 | c.4810G>C (p.Gly1604Arg) | SNV | Pathogenic |
SpliceAI Predictions
Total Splice-Altering Variants: 5,420
TOP 50 High-Confidence Splice Predictions (Delta Score >0.5)
| Variant | Effect | Delta Score |
|---|
| 3:38551555:GTGCC>G | acceptor_loss | 0.99 |
| 3:38551556:TGCC>T | acceptor_loss | 0.99 |
| 3:38551557:GCCT>G | acceptor_loss | 0.99 |
| 3:38551558:CCT>C | acceptor_loss | 0.99 |
| 3:38551556:TGC>T | acceptor_gain | 0.98 |
| 3:38551555:GTGC>G | acceptor_gain | 0.97 |
| 3:38551554:AGTGC>A | acceptor_gain | 0.95 |
| 3:38551557:GC>G | acceptor_gain | 0.95 |
| 3:38551558:CC>C | acceptor_gain | 0.95 |
| 3:38548201:C>CC | acceptor_gain | 0.74 |
| 3:38548533:GGACT>G | acceptor_gain | 0.67 |
| 3:38548535:ACTC>A | acceptor_gain | 0.65 |
| 3:38548223:C>T | acceptor_gain | 0.61 |
| 3:38548537:T>TG | acceptor_gain | 0.61 |
| 3:38548228:C>T | acceptor_gain | 0.60 |
| 3:38548534:GACTC>G | acceptor_gain | 0.53 |
| 3:38548196:CAGTT>C | acceptor_gain | 0.48 |
| 3:38548472:A>T | donor_gain | 0.44 |
| 3:38548538:C>G | acceptor_gain | 0.42 |
| 3:38548200:T>TC | acceptor_gain | 0.39 |
AlphaMissense Predictions
Total Missense Predictions: 13,357
Sample of Likely Pathogenic Predictions:
| Variant | Protein Change | AM Score | Classification |
|---|
| 3:38550325:A>T | V2016E | 0.606 | likely_pathogenic |
| Note |
|---|
| The majority of AlphaMissense predictions for SCN5A fall into "likely_benign" or "ambiguous" categories, consistent with the functional tolerance of many positions in the large protein. | |
| Biological Pathways & Gene Ontology** |
Reactome Pathways
Total: 2 pathways
| Pathway ID | Name |
|---|
| R-HSA-5576892 | Phase 0 - rapid depolarisation |
| R-HSA-445095 | Interaction between L1 and Ankyrins |
Gene Ontology Annotations
Total GO Terms: 79
Molecular Function (20 terms)
| GO ID | Term |
|---|
| GO:0005248 | voltage-gated sodium channel activity |
| GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential |
| GO:0086060 | voltage-gated sodium channel activity involved in AV node cell action potential |
| GO:0086061 | voltage-gated sodium channel activity involved in bundle of His cell action potential |
| GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential |
| GO:0086063 | voltage-gated sodium channel activity involved in SA node cell action potential |
| GO:0005516 | calmodulin binding |
| GO:0017134 | fibroblast growth factor binding |
| GO:0019899 | enzyme binding |
| GO:0019901 | protein kinase binding |
| GO:0019904 | protein domain specific binding |
| GO:0030506 | ankyrin binding |
| GO:0031625 | ubiquitin protein ligase binding |
| GO:0044325 | transmembrane transporter binding |
| GO:0050998 | nitric-oxide synthase binding |
| GO:0097110 | scaffold protein binding |
| GO:0005216 | monoatomic ion channel activity |
| GO:0005261 | monoatomic cation channel activity |
| GO:0005272 | sodium channel activity |
| GO:0005515 | protein binding |
Biological Process (TOP 20 of 46 terms)
| GO ID | Term |
|---|
| GO:0002027 | regulation of heart rate |
| GO:0003161 | cardiac conduction system development |
| GO:0003231 | cardiac ventricle development |
| GO:0006814 | sodium ion transport |
| GO:0035725 | sodium ion transmembrane transport |
| GO:0060048 | cardiac muscle contraction |
| GO:0086002 | cardiac muscle cell action potential involved in contraction |
| GO:0086005 | ventricular cardiac muscle cell action potential |
| GO:0086010 | membrane depolarization during action potential |
| GO:0086012 | membrane depolarization during cardiac muscle cell action potential |
| GO:0086014 | atrial cardiac muscle cell action potential |
| GO:0086015 | SA node cell action potential |
| GO:0086016 | AV node cell action potential |
| GO:0086043 | bundle of His cell action potential |
| GO:0086091 | regulation of heart rate by cardiac conduction |
| GO:0060307 | regulation of ventricular cardiac muscle cell membrane repolarization |
| GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization |
| GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization |
| GO:0051899 | membrane depolarization |
| GO:1902305 | regulation of sodium ion transmembrane transport |
Cellular Component (TOP 20 of 17 terms)
| GO ID | Term |
|---|
| GO:0001518 | voltage-gated sodium channel complex |
| GO:0005886 | plasma membrane |
| GO:0014704 | intercalated disc |
| GO:0042383 | sarcolemma |
| GO:0030315 | T-tubule |
| GO:0030018 | Z disc |
| GO:0005901 | caveola |
| GO:0009986 | cell surface |
| GO:0016328 | lateral plasma membrane |
| GO:0016020 | membrane |
| GO:0048471 | perinuclear region of cytoplasm |
| GO:0005783 | endoplasmic reticulum |
| GO:0005654 | nucleoplasm |
| GO:0005730 | nucleolus |
| GO:0034702 | monoatomic ion channel complex |
| GO:0070161 | anchoring junction |
| GO:0005737 | cytoplasm |
Section 8: Protein Interactions & Molecular Networks
Protein-Protein Interactions (STRING)
Total Interactions: 1,878
TOP 50 Highest-Confidence Interacting Proteins:
| Rank | UniProt | Gene | Confidence Score |
|---|
| 1 | Q14524 | SCN5A (self) | 987 |
| 2 | P02593 | CALM1 (Calmodulin) | 987 |
| 3 | Q12955 | ANK2 (Ankyrin-2) | 982 |
| 4 | Q12809 | KCNH2 (hERG) | 978 |
| 5 | P15382 | KCNE1 | 977 |
| 6 | Q9Y6J6 | KCNE1L | 977 |
| 7 | Q99959 | PKP2 (Plakophilin-2) | 976 |
| 8 | P51787 | KCNQ1 | 973 |
| 9 | Q07699 | SCN1B (Beta-1 subunit) | 967 |
| 10 | P27482 | CALM3 | 965 |
| 11 | Q8N335 | GPD1L | 965 |
| 12 | Q9NZT1 | CALML5 | 965 |
| 13 | Q8TD86 | SNTA1 (Syntrophin) | 964 |
| 14 | Q96GE6 | SCN3B (Beta-3 subunit) | 964 |
| 15 | Q8IWT1 | SCN4B (Beta-4 subunit) | 950 |
| 16 | Q9Y3Q4 | SCN2B (Beta-2 subunit) | 950 |
| 17 | Q92913 | TESC | 949 |
| 18 | O60258 | FGF13 | 928 |
| 19 | Q13424 | SNTA1 | 927 |
| 20 | P42658 | DLG1 (SAP97) | 909 |
| 21 | P56539 | CAV3 (Caveolin-3) | 897 |
| 22 | Q9Y6H6 | ANK3 | 892 |
| 23 | Q9NY72 | SCN3A | 891 |
| 24 | Q12959 | DLG4 | 890 |
| 25 | P48049 | SCN4A | 886 |
| 26 | P36382 | SCN2A | 879 |
| 27 | Q92736 | RYR2 | 873 |
| 28 | Q08289 | BMPK | 869 |
| 29 | P17302 | GJA1 (Connexin-43) | 868 |
| 30 | Q9HD47 | CAMK2D | 837 |
IntAct Interactions (Experimental)
Total: 172 experimentally validated interactions
TOP 30 Direct Interactions:
| Interactor Gene | Interaction Type | Confidence |
|---|
| CALM1 | direct interaction | 0.93 |
| FGF12 | direct/physical association | 0.54 |
| DLG1 | direct interaction | 0.61 |
| PTPN3 | direct interaction | 0.67 |
| SNTG2 | direct interaction | 0.66 |
| SNTA1 | direct interaction | 0.59 |
| ANK3 | direct interaction | 0.44 |
| SMURF2 | direct interaction | 0.44 |
| GPD1L | physical association | 0.40 |
| DLG2 | direct interaction | 0.44 |
| DLG3 | direct interaction | 0.44 |
| DLG4 | direct interaction | 0.44 |
| SNTB1 | direct interaction | 0.44 |
| PDZD2 | direct interaction | 0.44 |
| SNX27 | direct interaction | 0.44 |
| IL16 | direct interaction | 0.44 |
| MAGI1/2/3 | direct interaction | 0.44 |
| LDB3 | direct interaction | 0.44 |
| TJP1 | direct interaction | 0.44 |
| CASK | direct interaction | 0.44 |
Protein Structural Similarity (ESM2)
Total Similar Proteins: 62
TOP 20 Structurally Similar Proteins:
| UniProt | Top Similarity | Avg Similarity |
|---|
| A2APX8 | 1.0000 | 0.9927 |
| B1AWN6 | 0.9999 | 0.9936 |
| A2ASI5 | 0.9999 | 0.9932 |
| O88420 | 1.0000 | 0.9935 |
| O08562 | 0.9999 | 0.9934 |
| Q9WTU3 | 1.0000 | 0.9934 |
| Q9NY46 | 0.9994 | 0.9933 |
| Q99250 | 0.9998 | 0.9933 |
| Q15858 | 0.9997 | 0.9933 |
| P04774 | 1.0000 | 0.9927 |
| P04775 | 0.9999 | 0.9936 |
| P08104 | 0.9999 | 0.9931 |
| P35498 | 0.9999 | 0.9926 |
| Q6QIY3 | 0.9996 | 0.9929 |
| Q62968 | 0.9996 | 0.9928 |
| Q9UQD0 | 0.9999 | 0.9934 |
| Q62205 | 0.9999 | 0.9937 |
| O46669 | 0.9989 | 0.9930 |
| P0DMA5 | 0.9994 | 0.9929 |
| P02719 | 0.9970 | 0.9931 |
Protein Sequence Similarity (DIAMOND)
Total Homologous Proteins: 53
TOP 20 Sequence Homologs:
| UniProt | Identity % | Bitscore | Description |
|---|
| B1AWN6 | 99.6% | 3629 | Mouse Nav1.5 |
| A2APX8 | 99.4% | 3653 | Nav1.5 ortholog |
| P04774 | 99.4% | 3652 | SCN5A ortholog |
| O88420 | 99.1% | 3636 | Rat Nav1.5 |
| Q9WTU3 | 99.1% | 3640 | Nav1.5 ortholog |
| A2ASI5 | 98.8% | 3509 | Nav1.5 ortholog |
| P08104 | 98.8% | 3503 | Nav1.5 ortholog |
| Q99250 | 97.9% | 3564 | SCN8A/Nav1.6 |
| O08562 | 97.6% | 3595 | SCN5A ortholog |
| Q62205 | 97.6% | 3599 | Nav1.5 ortholog |
| Q01668 | 97.6% | 3962 | SCN2A/Nav1.2 |
| Q9JJV9 | 97.5% | 3736 | SCN1A/Nav1.1 |
| P15389 | 97.5% | 3729 | SCN8A/Nav1.6 |
| Q07652 | 98.2% | 3944 | SCN2A/Nav1.2 |
| Q61290 | 98.2% | 3953 | Mouse SCN2A |
| Q9UQD0 | 98.4% | 3599 | Nav1.5 ortholog |
| P35498 | 96.7% | 3605 | SCN9A/Nav1.7 |
| P15390 | 95.8% | 3269 | SCN4A/Nav1.4 |
| Q9ER60 | 95.8% | 3275 | SCN4A/Nav1.4 |
| Q15878 | 94.1% | 3872 | SCN3A/Nav1.3 |
Section 9: Transcription Factor Regulatory Data
Note: SCN5A encodes a voltage-gated sodium channel, not a transcription factor. This section covers regulatory information about SCN5A itself.
Upstream Transcriptional Regulators of SCN5A
Total: 20 known TF regulators (CollecTRI)
| TF Gene | Regulation | Confidence |
|---|
| TBX5 | Activation | - |
| FOXO1 | Activation | High |
| MYOG | Activation | - |
| ANK3 | Activation | - |
| TNF | Activation | - |
| CTNNB1 | Repression | - |
| ESR1 | Repression | - |
| FOXK1 | Repression | High |
| IL10 | Repression | - |
| TCF7L2 | Repression | - |
| SP1 | Unknown | High |
| IRF6 | Unknown | High |
| ESR2 | Unknown | Low |
| GTF3A | Unknown | Low |
| MAFB | Unknown | Low |
| NFKBIA | Unknown | Low |
| PARP1 | Unknown | Low |
| THRA | Unknown | Low |
| USF1 | Unknown | Low |
| VSX2 | Unknown | Low |
FANTOM5 Regulatory Elements
| - Promoter regions | - Enhancer regions |
|---|
| 2 | 13 | |
| | Drug & Pharmacology Data** |
ChEMBL Target Information
| Target ID | Type | Description |
|---|
| CHEMBL1980 | SINGLE PROTEIN | Sodium channel protein type 5 subunit alpha |
| CHEMBL2331043 | PROTEIN FAMILY | Sodium channel alpha subunit |
| CHEMBL4523669 | PROTEIN COMPLEX | SCN5A/SCN1B |
| CHEMBL4630763 | PROTEIN COMPLEX | SCN5A/SCN1B/SCN2B |
Approved Drugs Targeting Nav1.5 (Phase 4)
Total: 89 approved drugs
| ChEMBL ID | Drug Name | Mechanism |
|---|
| CHEMBL558 | MEXILETINE | Sodium channel blocker |
| CHEMBL1200606 | MEXILETINE HYDROCHLORIDE | Sodium channel blocker |
| CHEMBL1294 | QUINIDINE | Class Ia antiarrhythmic |
| CHEMBL633 | AMIODARONE | Class III antiarrhythmic |
| CHEMBL652 | FLECAINIDE | Class Ic antiarrhythmic |
| CHEMBL631 | PROPAFENONE | Class Ic antiarrhythmic |
| CHEMBL1404 | RANOLAZINE | Late Na current inhibitor |
| CHEMBL79 | LIDOCAINE | Local anesthetic/antiarrhythmic |
| CHEMBL698 | TETRACAINE | Local anesthetic |
| CHEMBL492 | ETIDOCAINE | Local anesthetic |
| CHEMBL1086 | DIBUCAINE | Local anesthetic |
| CHEMBL1374379 | BENZONATATE | Local anesthetic |
| CHEMBL108 | CARBAMAZEPINE | Anticonvulsant |
| CHEMBL16 | PHENYTOIN | Anticonvulsant |
| CHEMBL741 | LAMOTRIGINE | Anticonvulsant |
| CHEMBL744 | RILUZOLE | Neuroprotective |
| CHEMBL6966 | VERAPAMIL | Calcium channel blocker |
| CHEMBL193 | NIFEDIPINE | Calcium channel blocker |
| CHEMBL1491 | AMLODIPINE | Calcium channel blocker |
| CHEMBL1480 | FELODIPINE | Calcium channel blocker |
| CHEMBL1484 | NICARDIPINE | Calcium channel blocker |
| CHEMBL1428 | NIMODIPINE | Calcium channel blocker |
| CHEMBL1648 | ISRADIPINE | Calcium channel blocker |
| CHEMBL1726 | NISOLDIPINE | Calcium channel blocker |
| CHEMBL1008 | BEPRIDIL | Calcium/sodium channel blocker |
| CHEMBL27 | PROPRANOLOL | Beta-blocker |
| CHEMBL434394 | NEBIVOLOL | Beta-blocker |
| CHEMBL723 | CARVEDILOL | Beta/alpha-blocker |
| CHEMBL2107383 | VERNAKALANT HYDROCHLORIDE | Atrial-selective antiarrhythmic |
Additional Approved Drugs (Continued)
| ChEMBL ID | Drug Name | Class |
|---|
| CHEMBL11 | IMIPRAMINE | Antidepressant |
| CHEMBL72 | DESIPRAMINE | Antidepressant |
| CHEMBL629 | AMITRIPTYLINE | Antidepressant |
| CHEMBL1175 | DULOXETINE | Antidepressant |
| CHEMBL490 | PAROXETINE | Antidepressant |
| CHEMBL809 | SERTRALINE | Antidepressant |
| CHEMBL814 | FLUVOXAMINE | Antidepressant |
| CHEMBL71 | CHLORPROMAZINE | Antipsychotic |
| CHEMBL54 | HALOPERIDOL | Antipsychotic |
| CHEMBL85 | RISPERIDONE | Antipsychotic |
| CHEMBL716 | QUETIAPINE | Antipsychotic |
| CHEMBL42 | CLOZAPINE | Antipsychotic |
| CHEMBL1423 | PIMOZIDE | Antipsychotic |
| CHEMBL1621 | PALIPERIDONE | Antipsychotic |
| CHEMBL1237021 | LURASIDONE | Antipsychotic |
| CHEMBL3187365 | ASENAPINE | Antipsychotic |
| CHEMBL12713 | SERTINDOLE | Antipsychotic |
| CHEMBL1108 | DROPERIDOL | Antipsychotic |
| CHEMBL726 | FLUPHENAZINE | Antipsychotic |
| CHEMBL479 | THIORIDAZINE | Antipsychotic |
| CHEMBL657 | DIPHENHYDRAMINE | Antihistamine |
| CHEMBL1626 | CLEMASTINE | Antihistamine |
| CHEMBL17157 | TERFENADINE | Antihistamine (withdrawn) |
| CHEMBL296419 | ASTEMIZOLE | Antihistamine (withdrawn) |
| CHEMBL163 | RITONAVIR | Antiviral |
| CHEMBL729 | LOPINAVIR | Antiviral |
| CHEMBL584 | NELFINAVIR | Antiviral |
| CHEMBL1323 | DARUNAVIR | Antiviral |
| CHEMBL1241951 | LETERMOVIR | Antiviral |
Pharmacogenomics (PharmGKB)
| Attribute | Value |
|---|
| PharmGKB ID | PA304 |
| VIP Gene | Yes (Very Important Pharmacogene) |
| Has Variant Annotations | Yes |
| CPIC Guideline | No |
| Note |
|---|
| SCN5A is a VIP (Very Important Pharmacogene) due to its role in drug-induced arrhythmias and the pharmacogenomics of antiarrhythmic drug response. | |
| Expression Profiles** |
Overall Expression Pattern
| Attribute | Value |
|---|
| Expression Breadth | Ubiquitous |
| Total Present Calls | 161 |
| Maximum Expression Score | 95.49 |
TOP 30 Tissues by Expression (Bgee)
| Rank | Tissue | Expression Score | Quality |
|---|
| 1 | Apex of heart | 95.49 | Gold |
| 2 | Heart left ventricle | 93.12 | Gold |
| 3 | Cardiac ventricle | 92.91 | Gold |
| 4 | Right atrium auricular region | 92.69 | Gold |
| 5 | Cardiac atrium | 91.94 | Gold |
| 6 | Left ventricle myocardium | 91.09 | Gold |
| 7 | Heart right ventricle | 88.93 | Gold |
| 8 | Heart | 88.05 | Gold |
| 9 | Myocardium | 87.83 | Gold |
| 10 | Cardiac muscle of right atrium | 85.22 | Silver |
| 11 | Male germ line stem cell in testis | 82.53 | Silver |
| 12 | Primordial germ cell in gonad | 80.13 | Gold |
| 13 | Secondary oocyte | 74.40 | Silver |
| 14 | Sural nerve | 72.76 | Gold |
| 15 | Pigmented layer of retina | 71.27 | Silver |
| 16 | Ventricular zone | 70.42 | Gold |
| 17 | Ganglionic eminence | 65.11 | Gold |
| 18 | Endocervix | 62.34 | Gold |
| 19 | Adrenal tissue | 62.24 | Gold |
| 20 | Ascending aorta | 62.11 | Gold |
| 21 | Thoracic aorta | 62.09 | Gold |
| 22 | Primary visual cortex | 61.20 | Gold |
| 23 | Tibial nerve | 60.94 | Gold |
| 24 | Aorta | 59.33 | Gold |
| 25 | Gastrocnemius muscle | 58.96 | Gold |
| 26 | Descending thoracic aorta | 58.75 | Gold |
| 27 | Uterine cervix | 58.68 | Gold |
| 28 | Embryo | 58.32 | Gold |
| 29 | Prefrontal cortex | 58.19 | Gold |
| 30 | Muscle of leg | 57.93 | Gold |
Tissue-Specific Expression Pattern
SCN5A shows cardiac-enriched expression with highest levels in:
Heart chambers (ventricles > atria)
Cardiac conduction system (His bundle, Purkinje fibers)
Myocardium
Lower but detectable expression in:
Nervous system (brain, peripheral nerves)
Skeletal muscle
Smooth muscle (vasculature)
Reproductive tissues
Section 12: Disease Associations
GenCC Gene-Disease Associations
Total: 23 curated associations
| Disease | Classification | Inheritance | Submitter |
|---|
| Brugada syndrome 1 (OMIM:601144) | Definitive | AD | Multiple |
| Brugada syndrome (MONDO:0015263) | Definitive | AD | ClinGen |
| Long QT syndrome 3 (OMIM:603830) | Definitive | AD | Multiple |
| Dilated cardiomyopathy 1E (OMIM:601154) | Definitive | AD | Multiple |
| Progressive familial heart block, type 1A (OMIM:113900) | Strong/Moderate | AD/SD | Multiple |
| Sick sinus syndrome 1 (OMIM:608567) | Strong/Limited | AR/AD | Invitae |
Orphanet Disease Associations
Total: 8 rare diseases
| Orphanet ID | Disease Name | Gene Count | Type |
|---|
| 130 | Brugada syndrome | 22 | Disease |
| 101016 | Romano-Ward syndrome | 19 | Disease |
| 154 | Familial isolated dilated cardiomyopathy | 53 | Disease |
| 334 | Hereditary atrial fibrillation | 24 | Disease |
| 871 | Hereditary progressive cardiac conduction defect | 4 | Disease |
| 166282 | Hereditary sick sinus syndrome | 4 | Disease |
| 228140 | Idiopathic ventricular fibrillation | 2 | Disease |
| 1344 | Isolated atrial standstill | 2 | Disease |
HPO Phenotype Associations
Total: 105 phenotypes
TOP 50 Clinical Phenotypes:
| HPO ID | Phenotype |
|---|
| HP:0001657 | Prolonged QT interval |
| HP:0005184 | Prolonged QTc interval |
| HP:0001663 | Ventricular fibrillation |
| HP:0001664 | Torsade de pointes |
| HP:0004756 | Ventricular tachycardia |
| HP:0004751 | Paroxysmal ventricular tachycardia |
| HP:0011704 | Sick sinus syndrome |
| HP:0001688 | Sinus bradycardia |
| HP:0001662 | Bradycardia |
| HP:0001649 | Tachycardia |
| HP:0005110 | Atrial fibrillation |
| HP:0004757 | Paroxysmal atrial fibrillation |
| HP:0004754 | Permanent atrial fibrillation |
| HP:0004749 | Atrial flutter |
| HP:0025478 | Atrial standstill |
| HP:0001678 | Atrioventricular block |
| HP:0011705 | First degree atrioventricular block |
| HP:0011707 | Mobitz I atrioventricular block |
| HP:0012722 | Heart block |
| HP:0005170 | Complete heart block with broad QRS complexes |
| HP:0011710 | Bundle branch block |
| HP:0011712 | Complete right bundle branch block |
| HP:0011713 | Left bundle branch block |
| HP:0011711 | Left anterior fascicular block |
| HP:0005172 | Left posterior fascicular block |
| HP:0011715 | Trifascicular block |
| HP:0001644 | Dilated cardiomyopathy |
| HP:0001638 | Cardiomyopathy |
| HP:0001635 | Congestive heart failure |
| HP:0012664 | Reduced left ventricular ejection fraction |
| HP:0025169 | Left ventricular systolic dysfunction |
| HP:0001712 | Left ventricular hypertrophy |
| HP:0030682 | Left ventricular noncompaction |
| HP:0001645 | Sudden cardiac death |
| HP:0001699 | Sudden death |
| HP:0001695 | Cardiac arrest |
| HP:0001279 | Syncope |
| HP:0001962 | Palpitations |
| HP:0011675 | Arrhythmia |
| HP:0004308 | Ventricular arrhythmia |
| HP:0031546 | Cardiac conduction abnormality |
| HP:0012248 | Prolonged PR interval |
| HP:0012251 | ST segment elevation |
| HP:0005135 | Abnormal T-wave |
| HP:0031595 | Abnormal P wave |
| HP:0033122 | Absent P wave |
| HP:0000006 | Autosomal dominant inheritance |
| HP:0000007 | Autosomal recessive inheritance |
| HP:0003577 | Congenital onset |
| HP:0003581 | Adult onset |
GWAS Associations
Total: 193 GWAS associations
TOP 30 GWAS Traits:
| Study ID | Trait | P-value |
|---|
| GCST010321_94 | PR interval | 0 (highly significant) |
| GCST001735_5 | PR interval | 5×10⁻⁴³ |
| GCST007045_3 | PR interval | 1×10⁻⁶⁸ |
| GCST004826_15 | P wave duration | 2×10⁻⁴⁰ |
| GCST004826_4 | P wave duration | 1×10⁻³⁹ |
| GCST010321_119 | PR interval | 1×10⁻³⁴ |
| GCST008054_26 | QRS duration | 2×10⁻³¹ |
| GCST002500_20 | QT interval | 4×10⁻²⁷ |
| GCST000872_8 | QRS duration | 6×10⁻²² |
| GCST000872_7 | QRS duration | 2×10⁻²⁰ |
| GCST008422_1 | QRS duration | 1×10⁻²⁴ |
| GCST000562_8 | PR interval | 6×10⁻²⁶ |
| GCST001893_2 | ECG conduction measures | 3×10⁻²⁰ |
| GCST006414_123 | Atrial fibrillation | 3×10⁻¹⁶ |
| GCST005171_24 | QT interval | 1×10⁻¹⁵ |
| GCST000363_3 | QT interval | 1×10⁻¹⁴ |
| GCST002098_1 | Brugada syndrome | 1×10⁻¹⁴ |
| GCST006061_160 | Atrial fibrillation | 7×10⁻¹⁴ |
| GCST004826_11 | P wave duration | 3×10⁻¹⁴ |
| GCST003598_24 | QRS duration | 4×10⁻¹⁴ |
| GCST000364_7 | QT interval | 5×10⁻¹⁴ |
| GCST008042_5 | PR interval | 2×10⁻¹³ |
| GCST000872_12 | QRS duration | 1×10⁻¹⁶ |
| GCST001735_1 | PR interval | 4×10⁻¹² |
| GCST003818_26 | Resting heart rate | 1×10⁻¹¹ |
| GCST005905_11 | Global electrical heterogeneity | 3×10⁻¹¹ |
| GCST006414_122 | Atrial fibrillation | 7×10⁻¹² |
| GCST005080_5 | PR interval | 4×10⁻⁴¹ |
| GCST010796_3929 | ECG morphology | 1×10⁻⁵² |
| GCST010796_3927 | ECG morphology | 1×10⁻⁴⁸ |
SUMMARY STATISTICS
| Category | Count |
|---|
| Ensembl Transcripts | 16 |
| RefSeq Transcripts (human mRNA) | 11 |
| CCDS IDs | 6 |
| Exons (canonical) | 28 |
| UniProt Entries | 9 |
| Protein Length (aa) | 2,016 |
| PDB Structures | 14 |
| InterPro Domains | 9 |
| Pfam Domains | 4 |
| ClinVar Variants | 4,334 |
| SpliceAI Predictions | 5,420 |
| AlphaMissense Predictions | 13,357 |
| GO Terms | 79 |
| Reactome Pathways | 2 |
| STRING Interactions | 1,878 |
| IntAct Interactions | 172 |
| ESM2 Similar Proteins | 62 |
| DIAMOND Homologs | 53 |
| Approved Drugs (Phase 4) | 89 |
| GenCC Disease Associations | 23 |
| Orphanet Diseases | 8 |
| HPO Phenotypes | 105 |
| GWAS Associations | 193 |
| TF Regulators | 20 |
Data compiled from: HGNC, Ensembl, NCBI, UniProt, PDB, AlphaFold, ClinVar, SpliceAI, AlphaMissense, Reactome, Gene Ontology, STRING, IntAct, ChEMBL, PharmGKB, Bgee, GenCC, Orphanet, HPO, GWAS
Catalog, CollecTRI
I have compiled a comprehensive cross-database identifier and functional mapping reference for human SCN5A (sodium voltage-gated channel alpha subunit 5). This document serves as a definitive lookup
resource covering:
Key Highlights:
- Gene: HGNC:10593 | ENSG00000183873 | Entrez 6331 | OMIM 600163
- Location: Chr 3p22.2 (38,548,057-38,649,743, minus strand)
- Protein: Q14524 (2,016 aa, 227 kDa)
- Structures: 14 PDB entries including full-length cryo-EM structures
- Clinical Variants: 4,334 ClinVar entries with ~200+ pathogenic variants
- Drug Target: 89 approved drugs interact with Nav1.5 (VIP pharmacogene)
- Expression: Cardiac-enriched (highest in heart apex, ventricles, atria)
- Diseases: Brugada syndrome, Long QT syndrome 3, dilated cardiomyopathy, sick sinus syndrome, familial heart block
The reference includes all database identifiers, transcript/protein isoforms, structural data, variant annotations, AI predictions (SpliceAI, AlphaMissense), pathway memberships, protein
interactions, expression profiles, and disease associations organized across 12 comprehensive sections.